These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36194543)

  • 1. SpyPhage: A Cell-Free TXTL Platform for Rapid Engineering of Targeted Phage Therapies.
    Liyanagedera SBW; Williams J; Wheatley JP; Biketova AY; Hasan M; Sagona AP; Purdy KJ; Puxty RJ; Feher T; Kulkarni V
    ACS Synth Biol; 2022 Oct; 11(10):3330-3342. PubMed ID: 36194543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Engineering of Bacteriophage K1F with Human Epidermal Growth Factor to Enhance Killing of Intracellular
    Williams J; Kerven J; Chen Y; Sagona AP
    ACS Synth Biol; 2023 Jul; 12(7):2094-2106. PubMed ID: 37318278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering Bacteriophages as Versatile Biologics.
    Kilcher S; Loessner MJ
    Trends Microbiol; 2019 Apr; 27(4):355-367. PubMed ID: 30322741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PHEIGES: all-cell-free phage synthesis and selection from engineered genomes.
    Levrier A; Karpathakis I; Nash B; Bowden SD; Lindner AB; Noireaux V
    Nat Commun; 2024 Mar; 15(1):2223. PubMed ID: 38472230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SpyDisplay: A versatile phage display selection system using SpyTag/SpyCatcher technology.
    Kellmann SJ; Hentrich C; Putyrski M; Hanuschka H; Cavada M; Knappik A; Ylera F
    MAbs; 2023; 15(1):2177978. PubMed ID: 36803166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell Free Bacteriophage Synthesis from Engineered Strains Improves Yield.
    Brooks R; Morici L; Sandoval N
    ACS Synth Biol; 2023 Aug; 12(8):2418-2431. PubMed ID: 37548960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phage Engineering for Targeted Multidrug-Resistant
    Song J; Liu Z; Zhang Q; Liu Y; Chen Y
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covalent Modifications of the Bacteriophage Genome Confer a Degree of Resistance to Bacterial CRISPR Systems.
    Liu Y; Dai L; Dong J; Chen C; Zhu J; Rao VB; Tao P
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32938767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Engineering and Rebooting of Bacteriophages in L-Form Bacteria.
    Fernbach J; Meile S; Kilcher S; Loessner MJ
    Methods Mol Biol; 2024; 2734():247-259. PubMed ID: 38066374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of Leaderless-Bacteriocin-Producing Bacteriophage Targeting E. coli and Neighboring Gram-Positive Pathogens.
    Masuda Y; Kawabata S; Uedoi T; Honjoh KI; Miyamoto T
    Microbiol Spectr; 2021 Sep; 9(1):e0014121. PubMed ID: 34259542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering bacteriophages for enhanced host range and efficacy: insights from bacteriophage-bacteria interactions.
    Jia HJ; Jia PP; Yin S; Bu LK; Yang G; Pei DS
    Front Microbiol; 2023; 14():1172635. PubMed ID: 37323893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered K1F bacteriophages kill intracellular Escherichia coli K1 in human epithelial cells.
    Møller-Olsen C; Ho SFS; Shukla RD; Feher T; Sagona AP
    Sci Rep; 2018 Dec; 8(1):17559. PubMed ID: 30510202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-Cas9 Based Bacteriophage Genome Editing.
    Zhang X; Zhang C; Liang C; Li B; Meng F; Ai Y
    Microbiol Spectr; 2022 Aug; 10(4):e0082022. PubMed ID: 35880867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-free production of personalized therapeutic phages targeting multidrug-resistant bacteria.
    Emslander Q; Vogele K; Braun P; Stender J; Willy C; Joppich M; Hammerl JA; Abele M; Meng C; Pichlmair A; Ludwig C; Bugert JJ; Simmel FC; Westmeyer GG
    Cell Chem Biol; 2022 Sep; 29(9):1434-1445.e7. PubMed ID: 35820417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a genetically modified T7Select phage system to express the antimicrobial peptide 1018.
    Lemon DJ; Kay MK; Titus JK; Ford AA; Chen W; Hamlin NJ; Hwang YY
    J Microbiol; 2019 Jun; 57(6):532-538. PubMed ID: 31054139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic engineering and biological containment of bacteriophages.
    Mitsunaka S; Yamazaki K; Pramono AK; Ikeuchi M; Kitao T; Ohara N; Kubori T; Nagai H; Ando H
    Proc Natl Acad Sci U S A; 2022 Nov; 119(48):e2206739119. PubMed ID: 36409909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically Engineered Phages: a Review of Advances over the Last Decade.
    Pires DP; Cleto S; Sillankorva S; Azeredo J; Lu TK
    Microbiol Mol Biol Rev; 2016 Sep; 80(3):523-43. PubMed ID: 27250768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriophage isolated from non-target bacteria demonstrates broad host range infectivity against multidrug-resistant bacteria.
    Ngiam L; Schembri MA; Weynberg K; Guo J
    Environ Microbiol; 2021 Sep; 23(9):5569-5586. PubMed ID: 34390602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A guard-killer phage cocktail effectively lyses the host and inhibits the development of phage-resistant strains of Escherichia coli.
    Yu L; Wang S; Guo Z; Liu H; Sun D; Yan G; Hu D; Du C; Feng X; Han W; Gu J; Sun C; Lei L
    Appl Microbiol Biotechnol; 2018 Jan; 102(2):971-983. PubMed ID: 29150707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and Chemical Engineering of Phages for Controlling Multidrug-Resistant Bacteria.
    Guo D; Chen J; Zhao X; Luo Y; Jin M; Fan F; Park C; Yang X; Sun C; Yan J; Chen W; Liu Z
    Antibiotics (Basel); 2021 Feb; 10(2):. PubMed ID: 33669513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.